Medrio Raises $30M in First Equity Funding
Summary
Medrio, Inc., a San Francisco, CA-based healthcare technology company providing eClinical solutions for clinical trials, raised $30m in its first institutional equity funding.The company will use the funds to accelerate the deployment of its new software applications and expand its market position in the eClinical Founded in 2005 by CEO Mike Novotny, Medrio provides electronic data capture (EDC) solutions, collecting clinical trial data in a digitized form to help study sponsors and contract research organizations (CROs) set-up and conduct clinical trials.The company’s CloudEDC™ technology, which features a drag-and-drop interface, allows studies to be built quickly.The company recently introduced new software applications, including eSource, ePRO and eConsent.In conjunction with the investment, Ryan Drant, Founder and Managing Director of Questa Capital, and Brad Sloan, Managing Director of Questa Capital, joined Medrio’s board of directors, which now includes: – Mr. Novotny; – Richard Scheller, Ph.D., Chief Scientific Officer at 23andMe and former Executive Vice President of Research & Early Development at Genentech; – Dave Lipscomb, Co-founder of NetSuite; and – Doug Engfer, Founder and Former CEO of invivodata (acquired by ERT).
Funding
Classifications
AI Classifications
LabelsLinked Companies
